# US 2016/0237030 A1 · Synthetic intermediate of maxacalcitol, preparation method therefor and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0237030 A1
- Document ID: US20160237030A1
- Status: Published application
- Kind: A1
- Application number: 15/028,773
- Filed: 2014-10-11
- Published: 2016-08-18
- Earliest claimed: 2013-10-12
- Assignees: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Applicants: Zhejiang Hisun Pharmaceutical Co., Ltd.
- Inventors: Guojun ZHENG; Yaping WANG; Shi FENG
- Web page: https://patentgrep.com/patent/US20160237030A1

## CPC

- C07C 401/00: Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A61P 5/14: of the thyroid hormones, e.g. T3, T4
- A61P 17/06: Antipsoriatics
- C07D 303/22: with monohydroxy compounds
- C07D 333/72: Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
- C07F 7/1804: {Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896)}
- C07C 2601/14: The ring being saturated
- C07C 2602/24: the ring system containing nine carbon atoms, e.g. perhydroindane
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention provides a new method for synthesizing maxacalcitol and an intermediate thereof. According to the method, the maxacalcitol is creatively synthesized through the steps of: taking vitamin D2 as an initial raw material, obtaining a compound represented by formula II, oxidizing, chirally reducing, grafting with a side chain, introducing a hydroxyl group on the C-1 position, and photochemically overturning.

## Claims

### Claim 1

A compound represented by formula III:
where R is H or a hydroxyl protection group.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein the hydroxyl protection group is selected from a silicon ether protection group.

### Claim 3 (depends on 2)

The compound according to claim 2, wherein the hydroxyl protection group is selected from a t-butyldimethylsilyl, a trimethylsilyl, a triethylsilyl, a t-butyldiphenylsilyl or a triisoprolylsilyl.

### Claim 4 (depends on 1)

A preparation method for the compound III according to claim 1, wherein in the presence of a catalyst, oxidating compound II with an oxidizing agent to give compound III:

### Claim 5 (depends on 4)

The preparation method according to claim 4, wherein the oxidizing agent is selected from oxygen; the catalyst is selected from a copper catalyst.

### Claim 6 (depends on 4)

The preparation method according to claim 4, wherein the catalyst is 2,2-bipyridine copper complex.

### Claim 7 (depends on 1)

A compound represented by formula IV:
where R is defined as claim 1.

### Claim 8 (depends on 1, 7)

A preparation method for the compound IV according to claim 7, comprising in the presence of a chiral auxiliary reagent, reducing compound III with a borane to give compound IV:
where R is defined as claim 1.

### Claim 9 (depends on 8)

The preparation method according to claim 8, wherein the chiral auxiliary reagent is selected from (R)-2-methyl-CBS-oxazaborolidine, (R)-2-ethyl-CBS-oxazaborolidine or (R)-2-isopropyl-CBS-oxazaborolidine.

### Claim 10 (depends on 8)

The preparation method according to claim 8, wherein the borane is selected from BH3, borane-tetrahydrofuran complex, borane-triethylamine complex, borane-ethyl ether complex, borane-methyl sulfide complex or borane-N,N-diethylaniline complex.

### Claim 11 (depends on 8)

The preparation method according to claim 8, wherein a molar ratio of the compound III, the chiral auxiliary reagent and the borane is 1:(0.1-1):(1-2); the reaction temperature is −60° C. to 0° C.

### Claim 12 (depends on 11)

The preparation method according to claim 11, wherein the molar ratio of the compound III, the chiral auxiliary reagent and the borane is 1:0.6:1; the reaction temperature is −20° C.

### Claim 13 (depends on 1)

A compound represented by formula VI:
where R is defined as claim 1.

### Claim 14 (depends on 1, 13)

A preparation method for the compound VI according to claim 13, comprising:
Step 1: converting compound IV into compound V under alkaline condition:
Step 2: reacting compound V with 3-bromomethyl-2,2-dimethyloxirane to give compound VI:
where R is defined as claim 1 except for H.

### Claim 15 (depends on 14)

The preparation method according to claim 14, further comprising: de-protecting the hydroxyl protection group R of the compound VI obtained in the step 2 to give compound VI:
where R is H.

### Claim 16 (depends on 1)

A preparation method for Maxacalcitol represented by formula I:
which comprises:
Step 1: converting compound IV into compound V under alkaline condition:
Step 2: reacting compound V with 3-bromomethyl-2,2-dimethyloxirane to give compound VI:
Step 3: converting compound VI into compound VII in the presence of lithium triisobutylhydroborate:
Step 4: reacting compound VII under the action of both N-methylmorpholine N-oxide and selenium dioxide to give compound VIII:
Step 5: de-protecting the hydroxyl protection group of compound VIII to give compound IX:
Step 6: conducting a photochemical reaction on compound IX to give Maxacalcitol represented by formula I:
where R is defined as claim 1 except for H.

### Claim 17 (depends on 16)

The preparation method according to claim 16, which further comprises: in the presence of a chiral auxiliary reagent, reducing compound III with a borane to give compound IV:

### Claim 18 (depends on 17)

The preparation method according to claim 17, which further comprises: in the presence of a catalyst, oxidating compound II with an oxidizing agent to give compound III:

### Claim 19 (depends on 1)

A use of the compound III according to claim 1 in preparing Maxacalcitol.
